Genus announces £60 million share buyback

By the Editorial Team · Friday, September 11, 2026

Genus, an animal genetics firm, revealed a £60 million share buyback after reporting a 35% increase in adjusted pre-tax profit to £100.2 million, boosted by strong sales in China and Latin America. Despite the profit jump, cautious future guidance led to a 3.3% drop in shares, highlighting investor concerns about the company’s near-term growth.

Genus, a Basingstoke-based animal genetics company, announced a £60 million share buyback program following a reported 35 percent rise in adjusted pre-tax profit for the past year. The company’s profit increased to £100.2 million, driven in part by strong sales growth in China and Latin America.

Genus specializes in products designed to enhance livestock productivity and disease resistance, aiding farmers in improving animal yields and health. Despite the robust financial results, the company issued cautious forward guidance, which appeared to temper investor enthusiasm.

Following the announcement, Genus shares declined 3.3 percent, closing 74 pence lower at £21.60. The market reaction reflected concerns over the company’s outlook despite its solid performance in recent months. The share buyback is aimed at returning value to shareholders amid uncertainty about near-term growth prospects.

This article was reported by synthesizing coverage from multiple independent news outlets to present a balanced, unbiased account. Read about our editorial standards. Spotted an error? Let us know.